BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24368337)

  • 1. The proto-oncogene KRAS is targeted by miR-200c.
    Kopp F; Wagner E; Roidl A
    Oncotarget; 2014 Jan; 5(1):185-95. PubMed ID: 24368337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-200c inhibits breast cancer proliferation by targeting KRAS.
    Song C; Liu LZ; Pei XQ; Liu X; Yang L; Ye F; Xie X; Chen J; Tang H; Xie X
    Oncotarget; 2015 Oct; 6(33):34968-78. PubMed ID: 26392416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encapsulated miR-200c and Nkx2.1 in a nuclear/mitochondria transcriptional regulatory network of non-metastatic and metastatic lung cancer cells.
    D'Almeida O; Mothar O; Bondzie EA; Lieumo Y; Tagne L; Gupta S; Volkert T; Levine S; Tagne JB
    BMC Cancer; 2019 Feb; 19(1):136. PubMed ID: 30744585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
    Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
    BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targets of miR-200c mediate suppression of cell motility and anoikis resistance.
    Howe EN; Cochrane DR; Richer JK
    Breast Cancer Res; 2011 Apr; 13(2):R45. PubMed ID: 21501518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription factor and microRNA interactions in lung cells: an inhibitory link between NK2 homeobox 1, miR-200c and the developmental and oncogenic factors Nfib and Myb.
    Tagne JB; Mohtar OR; Campbell JD; Lakshminarayanan M; Huang J; Hinds AC; Lu J; Ramirez MI
    Respir Res; 2015 Feb; 16(1):22. PubMed ID: 25763778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process.
    Wang HY; Liu YN; Wu SG; Hsu CL; Chang TH; Tsai MF; Lin YT; Shih JY
    Cancer Biomark; 2020; 28(3):351-363. PubMed ID: 32417760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-200c dampens cancer cell migration via regulation of protein kinase A subunits.
    Sigloch FC; Burk UC; Biniossek ML; Brabletz T; Schilling O
    Oncotarget; 2015 Sep; 6(27):23874-89. PubMed ID: 26203557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma.
    Deng M; Tang H; Zhou Y; Zhou M; Xiong W; Zheng Y; Ye Q; Zeng X; Liao Q; Guo X; Li X; Ma J; Li G
    J Cell Sci; 2011 Sep; 124(Pt 17):2997-3005. PubMed ID: 21878506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA-200c inhibits invasion and metastasis of human non-small cell lung cancer by directly targeting ubiquitin specific peptidase 25.
    Li J; Tan Q; Yan M; Liu L; Lin H; Zhao F; Bao G; Kong H; Ge C; Zhang F; Yu T; Li J; He X; Yao M
    Mol Cancer; 2014 Jul; 13():166. PubMed ID: 24997798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-34a and miR-200c Have an Additive Tumor-Suppressive Effect on Breast Cancer Cells and Patient Prognosis.
    Mansoori B; Silvestris N; Mohammadi A; Khaze V; Baghbani E; Mokhtarzadeh A; Shanehbandi D; Derakhshani A; Duijf PHG; Baradaran B
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33673143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Downregulation of miR-200c Promotes Lactate Dehydrogenase A Expression and Non-Small Cell Lung Cancer Progression.
    Lei W; Kang W; Nan Y; Lei Z; Zhongdong L; Demin L; Lei S; Hairong H
    Oncol Res; 2018 Aug; 26(7):1015-1022. PubMed ID: 29321091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-200c inhibits apoptosis in pituitary adenoma cells by targeting the PTEN/Akt signaling pathway.
    Liao C; Chen W; Fan X; Jiang X; Qiu L; Chen C; Zhu Y; Wang H
    Oncol Res; 2013; 21(3):129-36. PubMed ID: 24512727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of miR-200c on the migration and invasion abilities of human prostate cancer Du145 cells and the corresponding mechanism.
    Shi R; Xiao H; Yang T; Chang L; Tian Y; Wu B; Xu H
    Front Med; 2014 Dec; 8(4):456-63. PubMed ID: 25363395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced expression of miR-200 family members contributes to antiestrogen resistance in LY2 human breast cancer cells.
    Manavalan TT; Teng Y; Litchfield LM; Muluhngwi P; Al-Rayyan N; Klinge CM
    PLoS One; 2013; 8(4):e62334. PubMed ID: 23626803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-200c downregulates HIF-1α and inhibits migration of lung cancer cells.
    Byun Y; Choi YC; Jeong Y; Lee G; Yoon S; Jeong Y; Yoon J; Baek K
    Cell Mol Biol Lett; 2019; 24():28. PubMed ID: 31061665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crucial role for early growth response-1 in the transcriptional regulation of miR-20b in breast cancer.
    Li D; Ilnytskyy Y; Kovalchuk A; Khachigian LM; Bronson RT; Wang B; Kovalchuk O
    Oncotarget; 2013 Sep; 4(9):1373-87. PubMed ID: 23945289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of miR-200c and its clinicopathological significance in patients with colorectal cancer.
    Roh MS; Lee HW; Jung SB; Kim K; Lee EH; Park MI; Lee JS; Kim MS
    Pathol Res Pract; 2018 Mar; 214(3):350-355. PubMed ID: 29496312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
    Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid transcription factor-1-regulated microRNA-532-5p targets KRAS and MKL2 oncogenes and induces apoptosis in lung adenocarcinoma cells.
    Griesing S; Kajino T; Tai MC; Liu Z; Nakatochi M; Shimada Y; Suzuki M; Takahashi T
    Cancer Sci; 2017 Jul; 108(7):1394-1404. PubMed ID: 28474808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.